Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A MUST READ
Reply New Message
Prev Message Back To Forum Threaded View Next Message

What they are saying on page 20 is that claim 29 was initially rejected as submitted by not only -9- rejections but also two -2-others...for a total of 11... all citing rule 35 USC 102 B (9) 102E (1) and 102A (1).

 In simple terms the are showing a total of -11- different prior art references against claim 29.

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply